Genotype-phenotype correlation in von Hippel-Lindau syndrome
Open Access
- 1 April 2001
- journal article
- review article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 10 (7) , 763-767
Abstract
The von Hippel-Lindau (VHL) syndrome (OMIM 193300) is an autosomal dominant disorder caused by deletions or mutations in a tumor suppressor gene on human chromosome 3p25. It is characterized clinically by vascular tumors including benign hemangioblastomas of the cerebellum, spine, brain stem and retina. Clear-cell renal cell carcinoma is a frequent cause of death, occurring in up to 70% of patients with VHL. Pheochromocytomas occur in association with specific alleles (usually mutations as opposed to deletions), therefore a family history of pheochromocytoma in association with VHL is an indication for thorough surveillance for pheochromocytoma in affected family members.The VHL gene coding sequence contains three exons. Two isoforms of mRNA exist, reflecting the presence or absence of exon 2. Tumors arise following the loss or inactivation of the wild-type allele in a cell. In initial studies ∼20% of patients had large germline mutations detectable by Southern blot analysis, 27% had missense mutations and 27% had nonsense or frameshift mutations. Advances in mutation analysis now allow for a 100% mutation detection rate in families with definite VHL. Families may be characterized by the presence [type 2 (7–20% of families)] or absence (type 1) of pheochromocytomas. Most type 2 families are affected by missense mutations, whereas most type 1 families have deletions or premature termination mutations. The prognosis for the lifetime risk of pheochromocytoma can be estimated by determination of the underlying mutation even if there is no family history of VHL.Keywords
This publication has 43 references indexed in Scilit:
- Genotype-phenotype correlations in families with deletions in the von Hippel-Lindau (VHL) geneHuman Genetics, 2000
- Clinical Characteristics of Ocular Angiomatosis in von Hippel-Lindau Disease and Correlation With Germline MutationArchives of Ophthalmology (1950), 1999
- Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor geneHuman Mutation, 1998
- Treatment of Renal Cell Carcinoma in Von Hippel-Lindau Disease: A Multicenter StudyJournal of Urology, 1995
- Original Articles: Kidney Cancer: Parenchymal Sparing Surgery in Patients With Hereditary Renal Cell CarcinomaJournal of Urology, 1995
- Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: Correlations with phenotypeHuman Mutation, 1995
- Von Hippel-Lindau disease: identification of deletion mutations by pulsed-field gel electrophoresisHuman Genetics, 1993
- Screening for von Hippel-Lindau Disease by DNA Polymorphism AnalysisJAMA, 1992
- Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locusThe Lancet, 1991
- Supratentorial haemangioblastoma: The diagnostic roles of computed tomography and angiographyClinical Radiology, 1981